An observational study in Telangiectasis, sponsored by UPECLIN HC FM Botucatu Unesp. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-10-18.
Sponsored by UPECLIN HC FM Botucatu Unesp · Observational
A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone.
All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up.
No new treatments were applied to the cohort.
69 studies on the registry are indexed under Telangiectasis; 12 are open to participants now.
Browse Telangiectasis studies →UPECLIN HC FM Botucatu Unesp is the lead sponsor of 65 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women between 18 and 90 years, with lower limb telangiectasias or reticular veins treated in previous studies with polidocanol plus hypertonic glucose or hypertonic glucose.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Previously treated with PDHG, no new interventions were performed.
Procedure: Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)
Previously treated with HG, no new interventions were performed.
Previously treated with PDHG, no new interventions were performed.
Procedure: Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)
Previously treated with HG, no new interventions were performed.
Patients previously treated were reassessed for long-term follow-up.
Also known as: Hypertonic Glucose 75% (HG)
Length of Telangiectasias in Centimeters
Total length of telangiectasias at day 730 for comparison with day 60 and assessment of disease relapse.
Time frame: 730 days
Length of Hyperchromia in Centimeters
Total length of hyperchromic stains at day 730 for comparison with day 60 and assessment of reversion.
Time frame: 730 days
Length of Matting in Centimeters
Total length of matting neovascularization at day 730 for comparison with day 60 and assessment of reversion.
Time frame: 730 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
UPECLIN HC FM Botucatu Unesp